2023-07-03 08:18:05 ET
- Ra Medical Systems ( NYSE: RMED ) has announced that it has undertaken a strong effort to expand its distribution outside of the US.
- Last week RMED announced it has filed for the CE Mark on LockeT, its new device to assist in closure of percutaneous puncture sites.
- The effort to expand international distribution reflects the anticipated timing of the receipt of the LockeT CE Mark, which is expected during this third quarter.
- Most recently, it has entered into a distribution agreement with Medilynq for distribution of RMED's products in certain countries in the Middle East, including Saudi Arabia, Jordon, Oman, UAE, Qatar, and Kuwait.
- Additionally, the company is working with Bioline, a new distributor in Spain, and recently attended a symposium/trade show in Spain exhibiting the company's products.
- RMED +20.65 % premarket to $1.11.
For further details see:
Ra Medical Systems' electrophysiology division expands international distribution